|
1）Sugisaki N, Hirata T, Naruse I, et al. Positional cues that are strictly localized in the telencepha-lon induce preferential growth of mitral cell axons. J Neurobiol. 1996; 29: 127-37
|
|
|
|
2）Beck S, Sakurai T, Eustace BK, et al. Fluorophore-assisted light inactivation: a high-throughput tool for direct target validation of proteins. Proteo-mics. 2002; 2: 247-55
|
|
|
|
|
|
3）Kawasaki T, Takagi Y, Yamatani H, et al. Systematic screening and identification of antigens recognized by monoclonal antibodies raised against the developing lateral olfactory tract. J Neurobiol. 2005; 62: 330-40
|
|
|
|
|
|
4）Steck E, Bräun J, Pelttari K, et al. Chondrocyte secreted CRTAC1: a glycosylated extracellular matrix molecule of human articular cartilage. Matrix Biol. 2007; 26: 30-41
|
|
|
|
|
|
5）Sato Y, Iketani M, Kurihara Y, et al. Cartilage acidic protein-1B(LOTUS), an endogenous Nogo receptor antagonist for axon tract formation. Science. 2011; 333: 769-73
|
|
|
|
|
|
6）Steck E, Benz K, Lorenz H, et al. Chondrocyte expressed protein-68 (CEP-68), a novel human marker gene for cultured chondrocytes. Biochem J. 2001; 353: 169-74
|
|
|
|
|
|
7）Hirokawa T, Boon-Chieng S, Mitaku S. SOSUI: classification and secondary structure prediction system for membrane proteins. Bioinformatics. 1998; 14: 378-9
|
|
|
|
|
|
8）Fournier AE, GrandPre T, Strittmatter SM. Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature. 2001; 409: 341-6
|
|
|
|
|
|
9）Liu BP, Fournier A, GrandPre T, et al. Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science. 2002; 297: 1190-3
|
|
|
|
|
|
10）Wang KC, Koprivica V, Kim JA, et al. Oligoden-drocyte-myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature. 2002; 417: 941-4
|
|
|
|
|
|
11）McGee AW, Strittmatter SM. The Nogo-66 receptor: focusing myelin inhibition of axon regeneration. Trends Neurosci. 2003; 26: 193-8
|
|
|
|
|
|
12）Yiu G, He Z. Glial inhibition of CNS axon regeneration. Nat Rev Neurosci. 2006; 7: 617-27
|
|
|
|
|
|
13）Schwab ME. Functions of Nogo proteins and their receptors in the nervous system. Nat Rev Neurosci. 2010; 11: 799-811
|
|
|
|
|
|
14）GrandPre T, Li S, Strittmatter SM. Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature. 2002; 417: 547-51
|
|
|
|
|
|
15）Kim JE, Liu BP, Park JH, et al. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury. Neuron. 2004; 44: 439-51
|
|
|
|
|
|
16）Li S, Liu BP, Budel S, et al. Blockade of Nogo-66, myelin-associated glycoprotein, and oligo-dendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury. J Neurosci. 2004; 24: 10511-20
|
|
|
|
|
|
17）Freund P, Schmidlin E, Wannier T, et al. Nogo-A-specific antibody treatment enhances sprouting and functional recovery after cervical lesion in adult primates. Nat Med. 2006; 12: 790-2
|
|
|
|
|
|
18）Cafferty WB, Duffy P, Huebner E, et al. MAG and OMgp synergize with Nogo-A to restrict axonal growth and neurological recovery after spinal cord trauma. J Neurosci. 2010; 30: 6825-37
|
|
|
|
|